Opgen ApS is a Danish APS based in København K, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2004, the company has 1 employee and reported a gross profit of -DKK 81.4k in its latest annual filing.
| Gross profit | -0.1M DKK | -122% |
| EBITDA | -0.3M DKK | +63% |
| Net profit | -0.1M DKK | +90% |
| Total assets | 5.2M DKK | -4% |
| Equity | -3.5M DKK | -2% |
| Employees | 1 | — |
In its most recent annual report (2020), Opgen ApS reported a gross profit of -DKK 81.4k, a decrease of 122% on the year before. The figures on this page draw on 5 annual filings covering 2016 to 2020. The bottom line showed a net loss of DKK 81.5k.
At the end of 2020, current assets covered short-term debt 0.6 times.
| Item | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Gross profit | -81 | 366 | 332 | 408 | -230 |
| Staff expenses | -191 | -1,112 | -1,054 | -1,019 | -1,082 |
| EBITDA | -273 | -745 | -722 | -610 | -1,312 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -273 | -745 | -722 | -610 | -1,312 |
| Net financials | 191 | -43 | -118 | 198 | -43 |
| Profit before tax | -81 | -788 | -840 | -412 | -1,355 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -81 | -788 | -840 | -412 | -1,355 |
| Item | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|
| Total assets | 5,225 | 5,432 | 6,118 | 653 | 655 |
| Equity | -3,526 | -3,444 | -2,656 | -1,816 | -1,404 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8,751 | 8,877 | 8,774 | 2,470 | 2,059 |
| Total debt | 8,751 | 8,877 | 8,774 | 2,470 | 2,059 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
Net profit as a percentage of total assets — the return generated on the capital employed.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|
DH Chief Executive Officer | Chief Executive Officer | 2012 – 2015 |
DB Chief Executive Officer | Chief Executive Officer | 2015 – 2015 |
TT Chief Executive Officer | Chief Executive Officer | 2004 – 2012 |
TC Management | Management | 2017 – 2021 |
KF Chief Executive Officer | Chief Executive Officer | 2015 – 2017 |
MS Founder | Founder | 2004 – 2022 |
MN Liquidator | Liquidator | 2021 – 2022 |
| Name | Role | Member since |
|---|
DH Board of Directors | Board of Directors | 2012 – 2015 |
HU Chairman | Chairman | 2012 – 2015 |
DB Board of Directors | Board of Directors | 2015 – 2015 |
TT Board of Directors | Board of Directors | 2004 – 2012 |
TC Board of Directors | Board of Directors | 2015 – 2021 |
EJ Chairman | Chairman | 2015 – 2020 |
IS Board of Directors | Board of Directors | 2012 – 2014 |
KF Board of Directors | Board of Directors | 2015 – 2017 |
MS Chairman | Chairman | 2004 – 2005 |
JT Chairman | Chairman | 2005 – 2012 |
TP Board of Directors | Board of Directors | 2014 – 2015 |
VM Board of Directors | Board of Directors | 2017 – 2021 |
CD Board of Directors | Board of Directors | 2015 – 2015 |
| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
AdvanDx Inc | Company | 100% | 100% | 2004 |
| Person | Role here | Other companies |
|---|---|---|
| Thais Taaning Johansen | Chief Executive Officer | 5 companies |
| Marianne Sigfusson | Founder | 4 companies |
| Morten Neergaard | Liquidator | 4 companies |
| Ingelise Saunders | Board of Directors | 2 companies |